2024
Combined Use of Guanfacine and N-Acetylcysteine for the Treatment of Cognitive Deficits After Traumatic Brain Injury
Khasnavis S, Belliveau T, Arnsten A, Fesharaki-Zadeh A. Combined Use of Guanfacine and N-Acetylcysteine for the Treatment of Cognitive Deficits After Traumatic Brain Injury. Neurotrauma Reports 2024, 5: 226-231. PMID: 38524728, PMCID: PMC10960163, DOI: 10.1089/neur.2023.0124.Peer-Reviewed Original ResearchTreatment of cognitive deficitsTraumatic brain injuryExecutive functionCognitive deficitsTraumatic brain injury clinicEfficacy of guanfacinePre-frontal cortexBrain injuryTreat traumatic brain injuryBehavioral therapyNeuropsychological testsCognitive symptomsCognitive changesPlacebo-controlled trialProcessing speedGuanfacineCortical functionOpen-label useApproved medicationsPersonsPost-treatmentDeficitsTraumatizationN-acetylcysteineMTBI
2008
Pharmacologic approaches to cognitive rehabilitation
McAllister T, Arnsten A. Pharmacologic approaches to cognitive rehabilitation. 2008, 298-320. DOI: 10.1017/cbo9781316529898.022.Peer-Reviewed Original ResearchCognitive rehabilitationCognitive neuroscienceCognitive changesEfficacy of interventionsVariety of populationsSuccessful interventionsRehabilitation successDifferent disordersNeuroscienceInterventionRehabilitationMemoryExternal factorsRole of imagingLanguagePharmacologic approachesDisordersNew findingsLatest developmentsClinical applicationPractical guidanceFindingsResearchEdition